TKT and neoplasm: To translate this strategy to clinical application, we are generating adenovirus vectors to deliver hypoxia-regulated TK, CD and UPRT genes into in vivo tumor models and to test whether triple gene transduction following GCV and 5-FC treatment will improve the efficacy of radiotherapy.